# ResearchSat — Public Updates Digest (May 2022 → May 2025)

*Compiled: 06 May 2025 (UTC +09:30)*

---

## 2025 Highlights

### Cryogenics Alliance with Onnes Cryogenics (26 Mar 2025)

ResearchSat announced a strategic partnership with Dutch‑Australian cryogenic pioneer **Onnes Cryogenics** to integrate advanced zero‑boil‑off cooling into forthcoming bioreactor satellites, enabling temperature‑sensitive pharma workflows in orbit. The accord was celebrated during a South‑Australian trade mission to Hyderabad. ([linkedin.com](https://www.linkedin.com/company/onnes-cryogenics/?utm_source=chatgpt.com), [hybiz.tv](https://hybiz.tv/hyderabad-and-south-australia-strengthen-innovation-ties/?utm_source=chatgpt.com))

### Lot Fourteen Feature on Microgravity Breakthroughs (21 Apr 2025)

Adelaide’s *Lot Fourteen* innovation precinct profiled ResearchSat’s expansion in South Australia, emphasising plans to scale bacteria‑based experiments and orbital manufacturing after earlier sub‑orbital successes. ([lotfourteen.com.au](https://lotfourteen.com.au/news/a-start-up-blasts-off-with-microgravity-research-at-the-forefront-of-its-mission/?utm_source=chatgpt.com))

### LinkedIn Knowledge Series – Regenerative Medicine in Space (19 Mar 2025)

A widely‑shared LinkedIn post explored how microgravity modulates stem‑cell pathways, positioning space bioprocessing as a cornerstone for next‑gen therapies. ([linkedin.com](https://www.linkedin.com/pulse/forging-path-pharmaceutical-industry-researchsat?utm_source=chatgpt.com))

### Editorial: *Space Bioreactors* as Catalysts for Discovery (08 Mar 2025)

In a long‑form article, ResearchSat detailed its roadmap for in‑space tissue engineering, drug discovery, and food‑tech applications of its proprietary ADI‑Lab platform. ([linkedin.com](https://www.linkedin.com/pulse/forging-path-pharmaceutical-industry-researchsat?utm_source=chatgpt.com))

### Industry Recognition – *Start‑ups to Watch 2025* (Apr 2025)

**SpaceConnect Online** listed ResearchSat among Australia’s five most innovative space ventures, citing AI‑driven feedback loops and scalable bioreactor design. ([spaceanddefense.io](https://spaceanddefense.io/aicraft-and-researchsat-partner/?utm_source=chatgpt.com))

---

## 2024 Momentum

### MoU with AICRAFT for Edge‑AI Payloads (17 Jan 2024)

A Memorandum of Understanding with edge‑computing firm **AICRAFT** will embed real‑time on‑orbit analytics into biological payloads, reducing downlink bandwidth and accelerating experiment iteration cycles. ([news.satnews.com](https://news.satnews.com/2024/01/17/aicraft-and-researchsat-partner-for-management-of-biological-experiments-in-space/?utm_source=chatgpt.com), [spaceanddefense.io](https://spaceanddefense.io/aicraft-and-researchsat-partner/?utm_source=chatgpt.com))

### SASIC Announcement – In‑Orbit Experiment Partnership (18 Jan 2024)

The South Australian Space Industry Centre highlighted the ResearchSat‑AICRAFT collaboration as a catalyst for new microgravity data‑sets and satellite operations fine‑tuning ahead of a December‑2024 sub‑orbital demonstrator mission. ([sasic.sa.gov.au](https://sasic.sa.gov.au/events-news-media/news/partnering-to-further-in-orbit-experiments/?utm_source=chatgpt.com), [australiandefence.com.au](https://www.australiandefence.com.au/defence/cyber-space/aicraft-and-researchsat-sign-mou?utm_source=chatgpt.com))

### ICC Newsletter – Cryogenics Partnership Spotlight (Aug 2024)

UniSA’s Innovation & Collaboration Centre newsletter showcased progress on the ResearchSat × Onnes Cryogenics venture, noting Seed Fund support and cross‑border tech transfer. ([icc.unisa.edu.au](https://icc.unisa.edu.au/newsletters/august-2024/?utm_source=chatgpt.com))

### ResearchSat Missions Page Refresh (Sep 2024)

A comprehensive update to ResearchSat’s missions portal detailed new sub‑orbital and low‑Earth‑orbit offerings, including module choices for protein crystallisation, antimicrobial resistance studies, and cell‑culture bioreactors. ([researchsat.space](https://researchsat.space/missions.html?utm_source=chatgpt.com))

---

## 2023–2022 Milestones

### Thought‑Leadership Articles on LinkedIn (2023)

* **Space, Science & Medicines** (23 Oct 2023) outlined microgravity‑driven drug‑discovery economics.
* **From Stars to Cells** (15 Aug 2023) linked space‑biology insights to terrestrial health advances.
* **Space & Agriculture Industry** (06 Jul 2023) examined microgravity’s role in climate‑resilient crop R\&D.
  ([linkedin.com](https://www.linkedin.com/pulse/forging-path-pharmaceutical-industry-researchsat?utm_source=chatgpt.com), [linkedin.com](https://www.linkedin.com/pulse/from-stars-cells-impact-space-biology-earthly-health-researchsat?utm_source=chatgpt.com))

### ADI‑Alpha CubeSat Launch & Follow‑Up (Nov 2022 → 2023)

ResearchSat’s first micro‑CubeSat, **ADI‑Alpha**, reached sub‑orbital space on 23 Nov 2022 aboard SSC’s SubOrbital Express‑3, achieving six minutes of <10⁻⁶ g microgravity for pharma payloads and safely recovering in Sweden. The milestone remained a reference point in 2023 media and investor communications. ([lotfourteen.com.au](https://www.lotfourteen.com.au/news/space-medtech-startup-takes-clinical-research-to-new-heights-to-improve-human-health-on-earthand-beyond/?utm_source=chatgpt.com), [sasic.sa.gov.au](https://sasic.sa.gov.au/events-news-media/news/local-start-up-reaches-new-heights-for-biomedical-space-research/?utm_source=chatgpt.com), [sscspace.com](https://sscspace.com/twelve-experiments-to-space-from-sweden/?utm_source=chatgpt.com))

### Lot Fourteen Early‑Stage Profile (Aug 2022)

A pre‑launch feature chronicled ResearchSat’s incubation at Lot Fourteen and its ambitions to accelerate antibiotic R\&D by sending bacteria into space, foreshadowing the ADI‑Alpha mission. ([lotfourteen.com.au](https://lotfourteen.com.au/news/a-start-up-blasts-off-with-microgravity-research-at-the-forefront-of-its-mission/?utm_source=chatgpt.com))
